About Annovis Bio (ANVS)
Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more
- USD5.05
- USD5.18
- USD4.96
- USD20.00
- -2.00%
- --
- 233.86k
- 488.51k
- 69M
- 4.21
- -56.30%
Stock News
4 hours ago
The U.S. economy is in a ‘sweet spot’. But markets may be getting one thing wrong, says Goldman Sachs.
MarketWatch
8 hours ago
Baron Real Estate Income Fund Q4 2024 Shareholder Letter
SeekingAlpha
8 hours ago
From Resilience To Revival: Commodities' Optimistic Outlook For 2025
SeekingAlpha
8 hours ago
Potbelly: The Cheapest Fast-Casual On The Market Is Starting To Get Noticed
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
